| Original language | English (US) |
|---|---|
| Article number | 1227095 |
| Journal | Frontiers in immunology |
| Volume | 14 |
| DOIs | |
| State | Published - 2023 |
Funding
Participation in this Research Topic was supported by funds granted to PA by the Alzheimer’s Association (AARG-22-974642), Alfred P. Sloan Foundation (JFRASE), and MSSM/CUNY Climate Change Health Impact Interdisciplinary Research Initiative, as well as generous support by Robin Chemers Neustein; to IA by Merck KGaA (Darmstadt, Germany), the Chan Zuckerberg Initiative (CZI), the HHMI International Scholar award, European Research Council Consolidator Grant (ERC-COG) 724471-HemTree2.0, an SCA award of the Wolfson Foundation and Family Charitable Trust, the Thompson Family Foundation, an MRA Established Investigator Award (509044), the Israel Science Foundation (703/15), the Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine, the Helen and Martin Kimmel award for innovative investigation, a NeuroMac DFG/Transregional Collaborative Research Center grant, International Progressive MS Alliance/NMSS PA-1604 08459, and an Adelis Foundation grant, and to CMC by the NIH National Institute of Allergy and Infectious Diseases to (1R01AI170938) and the Rheumatology Research Foundation (Innovative Research Award). The authors declare that this study received funding from Merck KGaA and the Chan Zuckerberg Initiative. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication. Acknowledgments
Keywords
- Alzheimer’s disease
- diabetic retinopathy
- glaucoma
- microbiome
- microglia
- pain
- retinal stroke
- traumatic brain injury
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
